$ALTO
Alto Ingredients, Inc. Stock $alto

$alto Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000121390023084784 Filed on November 08, 2023

Income Statement

Concept	2023 Q4	2023 Q3	2022 Q4
Revenue	$273.6M	$318.1M	$328.4M
YoY Change	-16.69%	-5.57%	-14.8%
Cost Of Revenue	$276.2M	$314.0M	$349.8M
YoY Change	-21.05%	-11.98%	1.86%
Gross Profit	-$2.525M	$4.161M	-$21.33M
YoY Change	-88.16%	-120.97%	-150.64%
Gross Profit Margin	-0.92%	1.31%	-6.49%
Selling, General & Admin	$8.383M	$8.488M	$7.551M
YoY Change	11.02%	14.66%	-19.74%
% of Gross Profit		203.99%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$5.700M	$5.640M	$5.973M
YoY Change	-4.57%	-9.9%	3.48%
% of Gross Profit		135.54%
Operating Expenses	$8.383M	$8.488M	$7.551M
YoY Change	11.02%	14.66%	-19.74%
Operating Profit	-$10.91M	-$4.327M	-$28.88M
YoY Change	-62.23%	-84.12%	-188.3%
Interest Expense	-$2.126M	-$2.000M	-$968.0K
YoY Change	119.63%	488.24%	324.56%
% of Operating Profit
Other Income/Expense, Net	$449.0K	$26.00K	$930.0K
YoY Change	-51.72%	-105.7%	64.02%
Pretax Income	-$18.85M	-$3.489M	-$31.15M
YoY Change	-39.49%	-87.56%	-182.8%
Income Tax	$97.00K		$1.925M
% Of Pretax Income
Net Earnings	-$19.26M	-$3.489M	-$33.39M
YoY Change	-42.31%	-87.56%	-192.38%
Net Earnings / Revenue	-7.04%	-1.1%	-10.17%
Basic Earnings Per Share		-$0.05
Diluted Earnings Per Share	-$0.26	-$0.05	-$0.46
COMMON SHARES
Basic Shares Outstanding	76.14M shares	75.91M shares	73.96M shares
Diluted Shares Outstanding		73.19M shares

Balance Sheet

Concept	2023 Q4	2023 Q3	2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$30.01M	$26.20M	$36.46M
YoY Change	-17.67%	-7.93%	-27.97%
Cash & Equivalents	$30.01M	$26.16M	$36.46M
Short-Term Investments
Other Short-Term Assets	$9.538M	$6.213M	$9.340M
YoY Change	2.12%	-30.7%	30.16%
Inventory	$52.61M	$57.09M	$66.63M
Prepaid Expenses
Receivables	$58.73M	$66.07M	$68.66M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$168.8M	$168.2M	$199.1M
YoY Change	-15.24%	-9.72%	-13.25%
LONG-TERM ASSETS
Property, Plant & Equipment	$248.7M	$248.9M	$239.1M
YoY Change	4.05%	6.6%	7.42%
Goodwill		$5.970M	$5.970M
YoY Change		0.0%
Intangibles	$8.498M	$8.645M	$9.087M
YoY Change	-6.48%		239.32%
Long-Term Investments
YoY Change
Other Assets	$5.628M	$6.013M	$6.137M
YoY Change	-8.29%	-11.42%	19.28%
Total Long-Term Assets	$285.5M	$292.9M	$279.2M
YoY Change	2.25%	9.14%	9.31%
TOTAL ASSETS
Total Short-Term Assets	$168.8M	$168.2M	$199.1M
Total Long-Term Assets	$285.5M	$292.9M	$279.2M
Total Assets	$454.2M	$461.1M	$478.3M
YoY Change	-5.03%	1.42%	-1.37%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$20.75M	$23.99M	$28.12M
YoY Change	-26.19%	37.14%	20.92%
Accrued Expenses	$20.21M	$16.64M	$26.56M
YoY Change	-23.92%	-24.93%	24.64%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$65.29M	$58.42M	$78.02M
YoY Change	-16.32%	7.16%	12.09%
LONG-TERM LIABILITIES
Long-Term Debt	$82.10M	$75.88M	$68.36M
YoY Change	20.1%	65.35%	35.73%
Other Long-Term Liabilities	$8.270M	$8.870M	$8.797M
YoY Change	-5.99%	-11.9%	-15.36%
Total Long-Term Liabilities	$90.37M	$84.75M	$77.15M
YoY Change	17.13%	51.45%	26.99%
TOTAL LIABILITIES
Total Short-Term Liabilities	$65.29M	$58.42M	$78.02M
Total Long-Term Liabilities	$90.37M	$84.75M	$77.15M
Total Liabilities	$174.7M	$163.1M	$170.2M
YoY Change	2.62%	36.3%	21.82%
SHAREHOLDERS EQUITY
Retained Earnings	-$763.9M	-$744.6M	-$734.6M
YoY Change	3.98%	6.19%	6.2%
Common Stock	$76.00K	$76.00K	$75.00K
YoY Change	1.33%	2.7%	2.74%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$279.6M	$298.0M	$308.1M
YoY Change
Total Liabilities & Shareholders Equity	$454.2M	$461.1M	$478.3M
YoY Change	-5.03%	1.42%	-1.37%

Cashflow Statement

Concept	2023 Q4	2023 Q3	2022 Q4
OPERATING ACTIVITIES
Net Income	-$19.26M	-$3.489M	-$33.39M
YoY Change	-42.31%	-87.56%	-192.38%
Depreciation, Depletion And Amortization	$5.700M	$5.640M	$5.973M
YoY Change	-4.57%	-9.9%	3.48%
Cash From Operating Activities	$11.79M	$23.13M	$4.209M
YoY Change	180.23%	-222.67%	-90.96%
INVESTING ACTIVITIES
Capital Expenditures	$4.921M	$6.640M	$12.51M
YoY Change	-60.67%	-142.92%	-401.91%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	$0.00
YoY Change		-100.0%	-100.0%
Cash From Investing Activities	-$4.921M	-$6.640M	-$12.51M
YoY Change	-60.67%	803.4%	-163.01%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	3.741M	-6.720M	25.41M
YoY Change	-85.28%	-70.44%	-162.21%
NET CHANGE
Cash From Operating Activities	11.79M	23.13M	4.209M
Cash From Investing Activities	-4.921M	-6.640M	-12.51M
Cash From Financing Activities	3.741M	-6.720M	25.41M
Net Change In Cash	10.61M	9.770M	17.11M
YoY Change	-37.97%	-123.08%	-33.09%
FREE CASH FLOW
Cash From Operating Activities	$11.79M	$23.13M	$4.209M
Capital Expenditures	$4.921M	$6.640M	$12.51M
Free Cash Flow	$6.874M	$16.49M	-$8.302M
YoY Change	-182.8%	-587.29%	-116.37%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	6732000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	8797000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	170232000	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	1000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	26556000	usd
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	75154000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	75154000	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	75000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1040834000	usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q4	us-gaap	Preferred Stock Liquidation Preference Value PreferredStockLiquidationPreferenceValue	18075000	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1822000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-734643000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	308089000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	478321000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	5970000	usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-21467
	dei	Entity Registrant Name EntityRegistrantName	ALTO INGREDIENTS, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	41-2170618
	dei	Entity Address Address Line1 EntityAddressAddressLine1	1300 South Second Street
	dei	Entity Address City Or Town EntityAddressCityOrTown	Pekin
	dei	Entity Address State Or Province EntityAddressStateOrProvince	IL
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	61554
	dei	City Area Code CityAreaCode	(916)
	dei	Local Phone Number LocalPhoneNumber	403-2123
	dei	Security12b Title Security12bTitle	Common Stock, $0.001 par value
	dei	Trading Symbol TradingSymbol	ALTO
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	76139100	shares
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	26162000	usd
CY2023Q3	us-gaap	Restricted Cash Current RestrictedCashCurrent	8699000	usd
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	51000	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	66065000	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	57092000	usd
CY2023Q3	us-gaap	Derivative Assets Current DerivativeAssetsCurrent	3974000	usd
CY2023Q3	us-gaap	Other Assets Current OtherAssetsCurrent	6213000	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	168205000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	248882000	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	23387000	usd
CY2023Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	8645000	usd
CY2023Q3	us-gaap	Goodwill Goodwill	5970000	usd
CY2023Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	6013000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	6137000	usd
CY2023Q3	us-gaap	Other Assets OtherAssets	44015000	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	40131000	usd
CY2023Q3	us-gaap	Assets Assets	461102000	usd
CY2022Q4	us-gaap	Assets Assets	478321000	usd
CY2023Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	23990000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	28115000	usd
CY2023Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	16644000	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	4044000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	3849000	usd
CY2023Q3	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	7249000	usd
CY2023Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	6488000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	12765000	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	58415000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	78017000	usd
CY2023Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	75878000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	68356000	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	19942000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	15062000	usd
CY2023Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	8870000	usd
CY2023Q3	us-gaap	Liabilities Liabilities	163105000	usd
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q3	us-gaap	Preferred Stock Liquidation Preference Value PreferredStockLiquidationPreferenceValue	18075000	usd
CY2023Q3	us-gaap	Preferred Stock Value PreferredStockValue	1000	usd
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	76115000	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	76115000	shares
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	76000	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1040747000	usd
CY2023Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1822000	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-744649000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	297997000	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	461102000	usd
CY2023Q3	us-gaap	Revenues Revenues	318127000	usd
CY2022Q3	us-gaap	Revenues Revenues	336877000	usd
	us-gaap	Revenues Revenues	949315000	usd
	us-gaap	Revenues Revenues	1007184000	usd
CY2023Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	313966000	usd
CY2022Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	356716000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	931137000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1013406000	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	4161000	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	-19839000	usd
	us-gaap	Gross Profit GrossProfit	18178000	usd
	us-gaap	Gross Profit GrossProfit	-6222000	usd
CY2023Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	8488000	usd
CY2022Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	7403000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	24281000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	24028000	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	574000	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-4327000	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-27242000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-6677000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-30250000	usd
CY2023Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-2000000	usd
CY2022Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-340000	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-5299000	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-859000	usd
CY2023Q3	alto	Income From Cash Grant IncomeFromCashGrant	2812000	usd
	alto	Income From Cash Grant IncomeFromCashGrant	2812000	usd
	alto	Income From Cash Grant IncomeFromCashGrant	22652000	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	26000	usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-456000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	104000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-68000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3489000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-28038000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-9060000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-8525000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-3489000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	24611000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	25233000	usd
	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	14766000	usd
	alto	Deferred Purchase Price Payments DeferredPurchasePricePayments	3500000	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	14685000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-28038000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-9060000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-8525000	usd
CY2023Q3	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	319000	usd
CY2022Q3	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	319000	usd
	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	946000	usd
	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	946000	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3808000	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-28357000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-10006000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-9471000	usd
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.39
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.14
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.13
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	73191000	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	73011000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	73464000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	71815000	shares
	us-gaap	Net Income Loss NetIncomeLoss	-9060000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-8525000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	17382000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	19122000	usd
	us-gaap	Derivative Gain On Derivative DerivativeGainOnDerivative	2463000	usd
	us-gaap	Derivative Gain On Derivative DerivativeGainOnDerivative	20164000	usd
	alto	Inventory Valuation InventoryValuation	7963000	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	574000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	2718000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	2546000	usd
	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	793000	usd
	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	29000	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	599000	usd
	alto	Bad Debtrecovery Expense BadDebtrecoveryExpense	-54000	usd
	alto	Bad Debtrecovery Expense BadDebtrecoveryExpense	-187000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2644000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-16137000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-9536000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	13290000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-3253000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-12692000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-4014000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-3799000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-11679000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-10684000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	10229000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1840000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-28111000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-25152000	usd
	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	6847000	usd
	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	-4452000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	2683000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1002000	usd
	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	946000	usd
	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	946000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3218000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-6400000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-14664000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-29712000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	49525000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	62125000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	34861000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	32413000	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	26162000	usd
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	28458000	usd
CY2023Q3	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	8699000	usd
CY2022Q3	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	3955000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	34861000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	32413000	usd
	us-gaap	Interest Paid Net InterestPaidNet	6063000	usd
	us-gaap	Interest Paid Net InterestPaidNet	961000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	7167000	usd
	us-gaap	Interest Paid Capitalized InterestPaidCapitalized	2185000	usd
	us-gaap	Interest Paid Capitalized InterestPaidCapitalized	209000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	308089000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	752000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	-6000	usd
CY2023Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	1682000	usd
CY2023Q1	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	312000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-13166000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	293675000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	959000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	-120000	usd
CY2023Q2	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	1001000	usd
CY2023Q2	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	315000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	7595000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	300793000	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	1007000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	5000	usd
CY2023Q3	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	319000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-3489000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	297997000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	345214000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	673000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	-9000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	1000	usd
CY2022Q1	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	312000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-2602000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	342965000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	1106000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	-2283000	usd
CY2022Q2	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	315000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	22115000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	363588000	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	767000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	2000	usd
CY2022Q3	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	1002000	usd
CY2022Q3	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	319000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-28038000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	334998000	usd
CY2023Q3	alto	Production Capacity ProductionCapacity	350000000	gal
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	51000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	105000	usd
CY2023Q3	us-gaap	Allowance For Loan And Lease Loss Recovery Of Bad Debts AllowanceForLoanAndLeaseLossRecoveryOfBadDebts	8000	usd
CY2022Q3	us-gaap	Allowance For Loan And Lease Loss Recovery Of Bad Debts AllowanceForLoanAndLeaseLossRecoveryOfBadDebts	253000	usd
	us-gaap	Allowance For Loan And Lease Loss Recovery Of Bad Debts AllowanceForLoanAndLeaseLossRecoveryOfBadDebts	54000	usd
	us-gaap	Allowance For Loan And Lease Loss Recovery Of Bad Debts AllowanceForLoanAndLeaseLossRecoveryOfBadDebts	187000	usd
CY2022Q3	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	50000000	afn
CY2023Q3	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	5000000	usd
	alto	Purchase Authorization Additional Lender Value PurchaseAuthorizationAdditionalLenderValue	5000000	usd
	alto	Purchase Additional Amount PurchaseAdditionalAmount	10000000	usd
	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	1249000	shares
	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	2683000	usd
CY2023Q3	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	1600000	shares
CY2023Q3	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	4008000	usd
	alto	Amount Allocated To Support Market Losses AmountAllocatedToSupportMarketLosses	700000000	usd
	alto	Income From Cash Grant IncomeFromCashGrant	2812000	usd
CY2023Q3	alto	Income From Cash Grant IncomeFromCashGrant	2812000	usd
	alto	Income From Cash Grant IncomeFromCashGrant	22652000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration:underline">Estimates and Assumptions</span></i> – The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates are required as part of determining the allowance for credit losses, net realizable value of inventory, long-lived asset impairments, valuation allowances on deferred income taxes, the potential outcome of future tax consequences of events recognized in the Company’s financial statements or tax returns, and the valuation of assets acquired and liabilities assumed as a result of business combinations. Actual results and outcomes may materially differ from management’s estimates and assumptions.</p>
CY2023Q3	us-gaap	Gross Profit GrossProfit	4161000	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	-19839000	usd
	us-gaap	Gross Profit GrossProfit	18178000	usd
	us-gaap	Gross Profit GrossProfit	-6222000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-3489000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-28038000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-9060000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-8525000	usd
CY2023Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	5647000	usd
CY2022Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	6260000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	17382000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	19122000	usd
CY2023Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-2000000	usd
CY2022Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-340000	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-5299000	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-859000	usd
CY2023Q3	us-gaap	Assets Assets	461102000	usd
CY2022Q4	us-gaap	Assets Assets	478321000	usd
CY2023Q3	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	4095000	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	4686000	usd
CY2023Q3	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	4950000	usd
CY2022Q4	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	5034000	usd
CY2023Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	0	usd
CY2022Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	4612000000	usd
CY2023Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	36835000	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	47736000	usd
CY2023Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	6363000	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	6396000	usd
CY2023Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	12502000	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	11197000	usd
CY2023Q3	us-gaap	Other Inventory OtherInventory	1392000	usd
CY2022Q4	us-gaap	Other Inventory OtherInventory	1299000	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	57092000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	66628000	usd
CY2023Q3	us-gaap	Long Term Debt LongTermDebt	84923000	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	78076000	usd
CY2023Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	75878000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	68356000	usd
CY2023Q3	us-gaap	Line Of Credit Facility Remaining Borrowing Capacity LineOfCreditFacilityRemainingBorrowingCapacity	53400000	usd
CY2023Q3	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	25000000	usd
CY2023Q3	us-gaap	Significant Supply Commitment Remaining Minimum Amount Committed SignificantSupplyCommitmentRemainingMinimumAmountCommitted	7863000000	usd
	us-gaap	Long Term Purchase Commitment Amount LongTermPurchaseCommitmentAmount	23639000000	usd
CY2022Q4	us-gaap	Derivative Assets Current DerivativeAssetsCurrent	4973000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-3489000	usd
CY2023Q3	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	319000	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3808000	usd
CY2023Q3	alto	Loss Available To Common Stockholders Shares Basicin Shares LossAvailableToCommonStockholdersSharesBasicinShares	73191000	shares
CY2023Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.05
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-28038000	usd
CY2022Q3	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	319000	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-28357000	usd
CY2022Q3	alto	Loss Available To Common Stockholders Shares Basicin Shares LossAvailableToCommonStockholdersSharesBasicinShares	73011000	shares
CY2022Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.39
	us-gaap	Net Income Loss NetIncomeLoss	-9060000	usd
	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	946000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-10006000	usd
	alto	Loss Available To Common Stockholders Shares Basicin Shares LossAvailableToCommonStockholdersSharesBasicinShares	73464000	shares
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.14
	us-gaap	Net Income Loss NetIncomeLoss	-8525000	usd
	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	946000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-9471000	usd
	alto	Loss Available To Common Stockholders Shares Basicin Shares LossAvailableToCommonStockholdersSharesBasicinShares	71815000	shares
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.13
CY2023Q3	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q3	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q3	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q3	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2022Q3	alto	Income From Cash Grant IncomeFromCashGrant		usd
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.13
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.14
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.39
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	71815000	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	73011000	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	73191000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	73464000	shares
	alto	Inventory Valuation InventoryValuation		usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges		usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium		usd
	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable		usd
	alto	Deferred Purchase Price Payments DeferredPurchasePricePayments		usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired		usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability		usd
CY2023Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent		usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent		usd
CY2023Q3	alto	Loss Available To Common Stockholders Shares Diluted LossAvailableToCommonStockholdersSharesDiluted	73191000	shares
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-3808000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.05
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-28357000	usd
CY2022Q3	alto	Loss Available To Common Stockholders Shares Diluted LossAvailableToCommonStockholdersSharesDiluted	73011000	shares
CY2022Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.39
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-10006000	usd
	alto	Loss Available To Common Stockholders Shares Diluted LossAvailableToCommonStockholdersSharesDiluted	73464000	shares
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.14
	alto	Loss Available To Common Stockholders Shares Diluted LossAvailableToCommonStockholdersSharesDiluted	71815000	shares
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-9471000	usd
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.13
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0000778164

Files In Submission

Name	View Source	Status
alto-20230930_cal.xml	Edgar Link	unprocessable
0001213900-23-084784-index-headers.html	Edgar Link	pending
0001213900-23-084784-index.html	Edgar Link	pending
0001213900-23-084784.txt	Edgar Link	pending
0001213900-23-084784-xbrl.zip	Edgar Link	pending
alto-20230930.xsd	Edgar Link	pending
f10q0923ex31-1_altoingred.htm	Edgar Link	pending
f10q0923ex31-2_altoingred.htm	Edgar Link	pending
f10q0923ex32-1_altoingred.htm	Edgar Link	pending
f10q0923_altoingred.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
alto-20230930_def.xml	Edgar Link	unprocessable
alto-20230930_lab.xml	Edgar Link	unprocessable
alto-20230930_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
f10q0923_altoingred_htm.xml	Edgar Link	completed
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ALTO
Alto Ingredients, Inc. Stock $alto

2023 Q4 Form 10-Q Financial Statement

#000121390023084784 Filed on November 08, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ALTO Alto Ingredients, Inc. Stock $alto

2023 Q4 Form 10-Q Financial Statement

#000121390023084784 Filed on November 08, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ALTO
Alto Ingredients, Inc. Stock $alto